Helicobacter pylori infection. Other and unspecified infectious diseases
Conditions
Interventions
Intervention 1: Azithromycin 250 mg/ bid /orally for 4 days and 250 mg/ daily/oral for additional 6 days, Amoxicillin 1 gr/bid/orally, Omeprazole 20 mg/bid/orally before meal both for 10 days. Interve
Treatment - Drugs
Azithromycin 250 mg/ bid /orally for 4 days and 250 mg/ daily/oral for additional 6 days, Amoxicillin 1 gr/bid/orally, Omeprazole 20 mg/bid/orally before meal both for 10 days
Clarithromycin 500 mg/bid/orally, Amoxicillin 1 gr/bid/orally and Omeprazole 20 mg/bid/orally before meal, for 10 days
Sponsors
Research Division of Qom University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Inclusion criteria: H pylori positive patients with endoscopically documented peptic ulcer disease, presence of erosive gastritis or duodenitis or patients with normal endoscopy but first degree relative with gastric cancer Exclusion criteria: age less than eighteen years old, gastric outlet obstructionT, history of allergy to penicillin derivatives
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Eradication of helicobacter pylori infection. Timepoint: after termination of 40 days course of treatment. Method of measurement: urease breath test. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactSeyed Saeid Sarkeshikian
Qom University of Medical Sciences
Outcome results
None listed